ResearcherCincinnati Children's Hospital Medical CenterNo recent work listed

Paul R. Andreassen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9760-1595; OpenAlex author ID A5010286459. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response. Last author DOI 10.1002/humu.24133 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sara H. Olson · 1 shared paper, 2021 · strength 0.12
- Paper The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise … DOI 10.1002/humu.24133 ↗
Yue Zhang · 1 shared paper, 2021 · strength 0.12
- Paper The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise … DOI 10.1002/humu.24133 ↗
Jie Chen · 1 shared paper, 2021 · strength 0.12
- Paper The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise … DOI 10.1002/humu.24133 ↗
Robert C. Kurtz · 1 shared paper, 2021 · strength 0.12
- Paper The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise … DOI 10.1002/humu.24133 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.